Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Nuclear factor kappa B (NF-κB) DNA consensus sequence is a specific 10-base pair genomic motif, typically represented as 5'-GGGRNNYYCC-3', found in the regulatory regions of genes involved in immunity and cell survival (Source: PubMed ID: 11244031). This sequence acts as the primary binding site for NF-κB transcription factor dimers, which are activated in response to stimuli like TNF-alpha, IL-1, or lipopolysaccharides (Source: Wikipedia). Once bound, NF-κB triggers the expression of a wide array of genes that drive inflammation, immune cell activation, and anti-apoptotic pathways (Source: Nat Rev Immunol). In many diseases, including chronic inflammation and cancer, the interaction between NF-κB and these DNA sequences is pathologically upregulated, leading to tissue damage or tumor progression (Source: NIH). Therapeutic intervention targeting these sequences often employs "decoy" oligonucleotides—synthetic DNA fragments that mimic the consensus sequence to sequester NF-κB proteins and prevent them from reaching the genome (Source: PubMed ID: 15123778). This strategy effectively silences the transcription of pro-inflammatory and pro-survival genes, offering a targeted approach to treating conditions like atopic dermatitis and rheumatoid arthritis (Source: AnGes MG).
Competitive inhibition of transcription factor binding via decoy oligonucleotides
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor kappa B DNA consensus sequence (NF-κB consensus sequence) (NF-κB consensus sequence).